AVERT Trial Collaboration group Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial. Lancet. 2015 Jul 4;386(9988):46-55. doi: 10.1016/S0140-6736(15)60690-0. Epub 2015 Apr 16. Erratum in: Lancet. 2015 Jul 4;386(9988):30. Erratum in: Lancet. 2017 May 13;389(10082):1884.
Biernaskie J, Chernenko G, Corbett D Efficacy of rehabilitative experience declines with time after focal ischemic brain injury. J Neurosci. 2004 Feb 4;24(5):1245-54.
Breceda EY, Dromerick AW Motor rehabilitation in stroke and traumatic brain injury: stimulating and intense. Curr Opin Neurol. 2013 Dec;26(6):595-601. doi: 10.1097/WCO.0000000000000024. Review.
Harris JE, Eng JJ, Miller WC, Dawson AS A self-administered Graded Repetitive Arm Supplementary Program (GRASP) improves arm function during inpatient stroke rehabilitation: a multi-site randomized controlled trial. Stroke. 2009 Jun;40(6):2123-8. doi: 10.1161/STROKEAHA.108.544585. Epub 2009 Apr 9.
Hsieh YW, Wang CH, Sheu CF, Hsueh IP, Hsieh CL Estimating the minimal clinically important difference of the Stroke Rehabilitation Assessment of Movement measure. Neurorehabil Neural Repair. 2008 Nov-Dec;22(6):723-7. doi: 10.1177/1545968308316385. Epub 2008 Sep 5.
Hsueh IP, Hsu MJ, Sheu CF, Lee S, Hsieh CL, Lin JH Psychometric comparisons of 2 versions of the Fugl-Meyer Motor Scale and 2 versions of the Stroke Rehabilitation Assessment of Movement. Neurorehabil Neural Repair. 2008 Nov-Dec;22(6):737-44. doi: 10.1177/1545968308315999. Epub 2008 Jul 21.
Iadecola C, Anrather J Stroke research at a crossroad: asking the brain for directions. Nat Neurosci. 2011 Oct 26;14(11):1363-8. doi: 10.1038/nn.2953.
Krakauer JW, Carmichael ST, Corbett D, Wittenberg GF Getting neurorehabilitation right: what can be learned from animal models? Neurorehabil Neural Repair. 2012 Oct;26(8):923-31. doi: 10.1177/1545968312440745. Epub 2012 Mar 30.
Kwah LK, Harvey LA, Diong J, Herbert RD Models containing age and NIHSS predict recovery of ambulation and upper limb function six months after stroke: an observational study. J Physiother. 2013 Sep;59(3):189-97. doi: 10.1016/S1836-9553(13)70183-8. Erratum in: J Physiother. 2013 Dec;59(4):218.
Langdon KD, Corbett D Improved working memory following novel combinations of physical and cognitive activity. Neurorehabil Neural Repair. 2012 Jun;26(5):523-32. doi: 10.1177/1545968311425919. Epub 2011 Dec 9.
Lynch E, Hillier S, Cadilhac D When should physical rehabilitation commence after stroke: a systematic review. Int J Stroke. 2014 Jun;9(4):468-78. doi: 10.1111/ijs.12262. Epub 2014 Mar 18. Review.
Mackay-Lyons M, McDonald A, Matheson J, Eskes G, Klus MA Dual effects of body-weight supported treadmill training on cardiovascular fitness and walking ability early after stroke: a randomized controlled trial. Neurorehabil Neural Repair. 2013 Sep;27(7):644-53. doi: 10.1177/1545968313484809. Epub 2013 Apr 18.
Mansfield A, Wong JS, Bryce J, Brunton K, Inness EL, Knorr S, Jones S, Taati B, McIlroy WE Use of Accelerometer-Based Feedback of Walking Activity for Appraising Progress With Walking-Related Goals in Inpatient Stroke Rehabilitation: A Randomized Controlled Trial. Neurorehabil Neural Repair. 2015 Oct;29(9):847-57. doi: 10.1177/1545968314567968. Epub 2015 Jan 20.
Murphy TH, Corbett D Plasticity during stroke recovery: from synapse to behaviour. Nat Rev Neurosci. 2009 Dec;10(12):861-72. doi: 10.1038/nrn2735. Epub 2009 Nov 4. Review.
Ploughman M, Windle V, MacLellan CL, White N, Doré JJ, Corbett D Brain-derived neurotrophic factor contributes to recovery of skilled reaching after focal ischemia in rats. Stroke. 2009 Apr;40(4):1490-5. doi: 10.1161/STROKEAHA.108.531806. Epub 2009 Jan 22.
Pollock A, St George B, Fenton M, Firkins L Top 10 research priorities relating to life after stroke--consensus from stroke survivors, caregivers, and health professionals. Int J Stroke. 2014 Apr;9(3):313-20. doi: 10.1111/j.1747-4949.2012.00942.x. Epub 2012 Dec 11.
Savitz SI, Cramer SC, Wechsler L; STEPS 3 Consortium Stem cells as an emerging paradigm in stroke 3: enhancing the development of clinical trials. Stroke. 2014 Feb;45(2):634-9. doi: 10.1161/STROKEAHA.113.003379. Epub 2013 Dec 24. Review.
Soleman S, Yip PK, Duricki DA, Moon LD Delayed treatment with chondroitinase ABC promotes sensorimotor recovery and plasticity after stroke in aged rats. Brain. 2012 Apr;135(Pt 4):1210-23. doi: 10.1093/brain/aws027. Epub 2012 Mar 6.
Stinear CM, Byblow WD Predicting and accelerating motor recovery after stroke. Curr Opin Neurol. 2014 Dec;27(6):624-30. doi: 10.1097/WCO.0000000000000153. Review.
Van Breukelen GJ ANCOVA versus change from baseline: more power in randomized studies, more bias in nonrandomized studies [corrected]. J Clin Epidemiol. 2006 Sep;59(9):920-5. Epub 2006 Jun 23. Erratum in: J Clin Epidemiol. 2006 Dec;59(12):1334.
Vickers AJ Analysis of variance is easily misapplied in the analysis of randomized trials: a critique and discussion of alternative statistical approaches. Psychosom Med. 2005 Jul-Aug;67(4):652-5.
Wang CH, Hsieh CL, Dai MH, Chen CH, Lai YF Inter-rater reliability and validity of the stroke rehabilitation assessment of movement (stream) instrument. J Rehabil Med. 2002 Jan;34(1):20-4.
Wang D, Fawcett J The perineuronal net and the control of CNS plasticity. Cell Tissue Res. 2012 Jul;349(1):147-60. doi: 10.1007/s00441-012-1375-y. Epub 2012 Mar 23. Review.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.